01/21/2026
Watch Dr. Beverly Davidson, Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics at Children's Hospital of Philadelphia, talk about her team's identification of two novel adeno-associated virus (AAV) capsid variants that could improve the cost, dosage, and precision of gene therapy to the brain. "Imagine looking at the night sky in New York City, where you'll see only the moon and a handful of stars," Dr. Davidson said. "That is the current state of gene therapy. What we've created here is like looking at the night sky over the Sahara Desert."
To learn more about our development of unique, leading-edge technologies at CHOP, check out our 2025 Annual Report: http://ms.spr.ly/6189QBeYt